Share This

Related Topics News -

     
 Title only   |   Print    Next page > 
     
基石藥業-B非執董增持近期共221.95萬股

2024-05-02T  
基石藥業-BCEO過去半年累計增持334.5萬股

2024-04-29T  
基石藥業-BRET抑制劑普吉華申請境內生產獲受理

2024-04-09T  
《公司業績》基石藥業全年虧損收窄至3.67億人民幣

2024-03-27T  
基石藥業-B舒格利單抗於內地獲批治療胃癌

2024-03-15T  
基石藥業-B被剔出港股通後現挫26% 公司確認運作正常

2024-03-04T  
中通快遞獲納入港股通名單 現飆升一成

2024-03-04T  
深交所:今日調整深港通下港股通證券名單

2024-03-04T  
《大行報告》中金:國指及科指檢討結果料對聯通及同程影響正面 22隻股份或符納入港股通

2024-02-20T  
基石藥業(02616.HK)以5,000萬美元向施維雅出售「拓舒沃」大中華及新加坡獨家權益

2023-12-21T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.